Drugmakers agree to 29 percent hike in regulator fees (Asbury Park Press)
Drugmakers, who represent New Jersey's biggest industry, agreed to a 29 percent increase in payments to U.S. regulators to ensure speedy approvals of new medicines and step up safety monitoring, according to the Food and Drug Administration. Payments to the FDA for new-medicine applications would jump by at least $87.3 million to $392.8 million in the fiscal year starting in October, according to ...

FDA orders retesting for MDS lab clients (The Globe and Mail)
The U.S. Food and Drug Administration has told a number of pharmaceutical companies to confirm or repeat studies done for them by a unit of MDS Inc. because of concerns about their accuracy.